Polysomnography Validation of the Sansa Device

NCT ID: NCT06070389

Last Updated: 2024-08-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

533 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-06-01

Study Completion Date

2023-12-13

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of this study is to evaluate the performance of the Sansa device for the diagnosis of sleep disordered breathing.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sleep-Disordered Breathing

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Sansa device

The Sansa device will be used during a single overnight polysomnography study.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18 years of age or older
* able to read, understand, and sign informed consent documentation
* willing to sleep with the Sansa device and PSG simultaneously in the sleep clinic
* suspected or known to have sleep disordered breathing

Exclusion Criteria

* exhibit deformities of the chest that would interfere with sensor placement
* have broken or injured skin that would interfere with sensor placement
* known to experience adverse reactions to medical-grade adhesive
* diagnosed with hypoventilation
* diagnosed with severe chronic obstructive pulmonary disease
* exhibit symptoms of significant non-respiratory sleep disorders
* diagnosed with a neuromuscular disorder leading to muscle weakness
* chronically use supplemental oxygen at night or during the day
* pregnant
* scheduled to undergo titration of a hypoglossal nerve stimulation device
* undergo permanent pacing with an implanted pacemaker
* diagnosed with congestive heart failure with an ejection fraction less than 45%
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Huxley Medical, Inc.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Cathy Goldstein

Role: PRINCIPAL_INVESTIGATOR

University of Michigan

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Pulmonary & Sleep Specialists

Decatur, Georgia, United States

Site Status

University of Michigan

Ann Arbor, Michigan, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Goldstein C, Ghanbari H, Sharma S, Collop N, Namen A, Kirsch DB, Drucker M, Khayat R, Pollock M, Torstrick B, Walsh C, Herreshoff E, Frankel DS, Rosen IM. Polysomnography validation of SANSA to detect obstructive sleep apnea. Front Neurol. 2025 Jun 16;16:1592690. doi: 10.3389/fneur.2025.1592690. eCollection 2025.

Reference Type DERIVED
PMID: 40589991 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

EDS-50031

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

DreamKit Diagnostic Validation
NCT04671342 COMPLETED NA
AirSense 10 AHI Validation Study
NCT03043703 WITHDRAWN NA